Stockscreener 앱 받기
86.06
1.62%
1.37
시간 외 거래:
86.06
Disc Medicine Inc 주식(IRON)의 최신 뉴스
Disc Medicine to present initial DISC-0974 data from RALLY-MF trial - Investing.com Australia
Disc Medicine (NASDAQ:IRON) Earns Buy Rating from Analysts at Stifel Nicolaus - MarketBeat
Will Disc Medicine Inc. stock recover faster than marketMarket Performance Recap & Fast Gaining Stock Strategy Reports - newser.com
Is Disc Medicine Inc. stock trading near support levelsInsider Buying & Long Hold Capital Preservation Plans - newser.com
Disc Medicine Inc. stock momentum explainedPortfolio Value Report & Free Weekly Watchlist of Top Performers - newser.com
Is Disc Medicine Inc. stock attractive for passive investors2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Stifel Reiterates Disc Medicine (IRON) Buy Recommendation - Nasdaq
Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting - The Manila Times
Disc Medicine (NASDAQ: IRON) to present RALLY-MF Phase 2 data at ASH with JAK combos - Stock Titan
What makes Disc Medicine Inc. stock attractive to growth fundsJuly 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
IRON: Stifel Reinstates 'Buy' Rating with New Price Target of $1 - GuruFocus
Disc Medicine (IRON) Receives Buy Rating with Promising Outlook - GuruFocus
How to escape a deep drawdown in Disc Medicine Inc.2025 Trading Volume Trends & Community Verified Swing Trade Signals - newser.com
How sustainable is Disc Medicine Inc. stock dividend payoutQuarterly Portfolio Summary & AI Powered Market Entry Ideas - newser.com
Applying Wyckoff theory to Disc Medicine Inc. stockJuly 2025 Fed Impact & Advanced Technical Analysis Signals - newser.com
Is Disc Medicine Inc. stock in correction or buying zoneGold Moves & Low Drawdown Trading Strategies - newser.com
Can Disc Medicine Inc. stock weather global recession2025 Key Lessons & Growth Focused Entry Reports - newser.com
Will Disc Medicine Inc. stock maintain growth storyJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - newser.com
How Disc Medicine Inc. stock performs in interest rate cyclesJuly 2025 Movers & Safe Entry Point Identification - newser.com
Why Disc Medicine Inc. stock is considered a top pickExit Point & Entry Point Confirmation Signals - newser.com
Morgan Stanley Issues Positive Forecast for Disc Medicine (NASDAQ:IRON) Stock Price - MarketBeat
Disc Medicine stock reiterated Strong Buy at Raymond James on DISC-0974 potential - Investing.com
Analysts Conflicted on These Healthcare Names: Kyverna Therapeutics, Inc. (KYTX), Disc Medicine (IRON) and Baxter International (BAX) - The Globe and Mail
Disc Medicine to Participate in Upcoming Investor Conferences - Enidnews.com
Disc Medicine (NASDAQ: IRON) to appear at Guggenheim, Stifel, Jefferies; live webcasts - Stock Titan
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
What valuation multiples suggest for Disc Medicine Inc. stockEarnings Growth Summary & Real-Time Chart Breakout Alerts - newser.com
WilmerHale Advises Underwriters in $287.5 Million Public Offering of Disc Medicine - WilmerHale
IRON Stock: Morgan Stanley Raises Price Target to $115 | IRON St - GuruFocus
Morgan Stanley Raises Price Target on Disc Medicine to $115 From $90, Keeps Overweight Rating - MarketScreener
Disc Medicine’s Promising Anemia Treatment Study: Key Insights for Investors - MSN
Chronic Kidney Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Jiangsu HengRui, Disc Medicine, 3SBio, Kind Pharma, Jiangsu Hansoh Pharm - Barchart.com
Disc Medicine (IRON): Evaluating Valuation After New Clinical Trial Plans and FDA Recognition Boost Pipeline Momentum - Yahoo Finance
Disc Medicine, Inc. (IRON) stock forecast and price target - Yahoo! Finance UK
Disc Medicine planning trial of iron overload treatment for sickle cell - Sickle Cell Disease News
Aug Chart Watch: Why Disc Medicine Inc. stock is considered a top pickQuarterly Earnings Summary & Daily Entry Point Trade Alerts - fcp.pa.gov.br
Why Disc Medicine Inc. stock remains a top recommendationWeekly Trading Summary & Accurate Intraday Trade Tips - fcp.pa.gov.br
1.45%
0.86%
자본화:
|
볼륨(24시간):